Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Martin H. Schuler, Rossana Berardi, Wan-Teck Lim, Robin Van Geel, Maja J. De Jonge, Todd Michael Bauer, Analia Azaro, Maya Gottfried, Ji-Youn Han, Dae Ho Lee, Mira Wollner, David S. Hong, Arndt Vogel, Angelo Delmonte, Alexander Krohn, Yong Zhang et al | ||||||||||||
Title | Phase (Ph) I study of the safety and efficacy of the cMET inhibitor capmatinib (INC280) in patients (pts) with advanced cMET+ non-small cell lung cancer (NSCLC). | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/165406-176 | ||||||||||||
Abstract Text | J Clin Oncol 34, 2016 (suppl; abstr 9067) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|